Avalon Trust Co Reduces Stock Holdings in The Cooper Companies, Inc. $COO

Avalon Trust Co cut its holdings in The Cooper Companies, Inc. (NASDAQ:COO) by 97.6% in the third quarter, according to the company in its most recent disclosure with the SEC. The fund owned 4,960 shares of the medical device company’s stock after selling 202,070 shares during the quarter. Avalon Trust Co’s holdings in Cooper Companies were worth $340,000 at the end of the most recent reporting period.

Other large investors have also modified their holdings of the company. CYBER HORNET ETFs LLC purchased a new position in shares of Cooper Companies in the 2nd quarter valued at approximately $36,000. MUFG Securities EMEA plc purchased a new position in shares of Cooper Companies in the second quarter worth $42,000. Assetmark Inc. lifted its stake in shares of Cooper Companies by 357.8% during the second quarter. Assetmark Inc. now owns 618 shares of the medical device company’s stock worth $44,000 after buying an additional 483 shares during the period. Quent Capital LLC purchased a new stake in shares of Cooper Companies during the third quarter valued at $44,000. Finally, Mather Group LLC. acquired a new position in shares of Cooper Companies in the 3rd quarter valued at $56,000. Hedge funds and other institutional investors own 24.39% of the company’s stock.

Wall Street Analyst Weigh In

A number of brokerages have commented on COO. Barclays set a $98.00 price target on Cooper Companies and gave the stock an “overweight” rating in a research report on Monday, January 26th. Morgan Stanley upped their target price on Cooper Companies from $76.00 to $83.00 and gave the company an “equal weight” rating in a research report on Monday, December 8th. Piper Sandler reissued an “overweight” rating and set a $94.00 price target (up from $83.00) on shares of Cooper Companies in a research report on Friday, December 5th. JPMorgan Chase & Co. lifted their price objective on shares of Cooper Companies from $66.00 to $78.00 and gave the company a “neutral” rating in a research note on Friday, December 5th. Finally, Mizuho set a $100.00 price objective on shares of Cooper Companies and gave the stock an “outperform” rating in a research note on Friday, December 5th. One investment analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating, six have given a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat, Cooper Companies currently has an average rating of “Moderate Buy” and a consensus price target of $90.77.

Cooper Companies Stock Performance

COO opened at $84.07 on Monday. The firm has a fifty day moving average price of $82.12 and a 200 day moving average price of $75.30. The Cooper Companies, Inc. has a 1 year low of $61.78 and a 1 year high of $92.84. The stock has a market cap of $16.48 billion, a P/E ratio of 44.72, a P/E/G ratio of 2.40 and a beta of 1.03. The company has a debt-to-equity ratio of 0.30, a current ratio of 1.89 and a quick ratio of 1.13.

Cooper Companies (NASDAQ:COO) last released its quarterly earnings results on Thursday, December 4th. The medical device company reported $1.15 EPS for the quarter, beating the consensus estimate of $1.11 by $0.04. The company had revenue of $1.07 billion for the quarter, compared to analyst estimates of $1.06 billion. Cooper Companies had a net margin of 9.16% and a return on equity of 10.02%. The firm’s revenue was up 4.6% on a year-over-year basis. During the same quarter last year, the business earned $1.04 earnings per share. Cooper Companies has set its FY 2026 guidance at 4.450-4.600 EPS and its Q1 2026 guidance at 1.020-1.040 EPS. Equities research analysts anticipate that The Cooper Companies, Inc. will post 3.98 earnings per share for the current year.

Insider Buying and Selling

In other Cooper Companies news, insider Holly R. Sheffield acquired 1,230 shares of the company’s stock in a transaction on Tuesday, December 16th. The shares were bought at an average cost of $80.75 per share, with a total value of $99,322.50. Following the completion of the acquisition, the insider owned 39,052 shares in the company, valued at approximately $3,153,449. This trade represents a 3.25% increase in their ownership of the stock. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, CEO Albert G. White III bought 10,000 shares of Cooper Companies stock in a transaction dated Tuesday, December 16th. The shares were acquired at an average cost of $80.80 per share, with a total value of $808,000.00. Following the completion of the purchase, the chief executive officer owned 236,151 shares in the company, valued at approximately $19,081,000.80. This trade represents a 4.42% increase in their ownership of the stock. The SEC filing for this purchase provides additional information. Insiders have acquired a total of 16,014 shares of company stock worth $1,304,416 in the last ninety days. 1.98% of the stock is owned by corporate insiders.

Cooper Companies Profile

Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.